Company Profiles

driven by the PitchBook Platform

Neograft Technologies

Description

Developer of medical devices and cardiac technologies for use in heart bypass procedures. The company’s products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts.

2009

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$11M

Latest Deal Amount

$32.3M

Total Amount Raised

Description

Developer of medical devices and cardiac technologies for use in heart bypass procedures. The company’s products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts.

Website:

www.neograftinc.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Primary Office

470 Constitution Drive Taunton, MA 02780United States +1 (508) 802-4122
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Neograft Technologies's full profile, request a free trial.

Neograft Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Neograft Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Neograft Technologies Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
MAG VenturesGrowth/ExpansionMinority000 0000000 0000
MAG Ventures Growth/Expansion

Neograft Technologies Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Jon McGrathPresident, Board Member & Chief Executive Officer
Mohammed El-KurdiCo-Founder and Director, Science and Engineering
David VorpCo-Founder & Advisor
William WagnerCo-Founder & Advisor
Steve LinharesVice President of Quality, Clinical & Regulatory
Jon McGrath President, Board Member & Chief Executive Officer
Mohammed El-Kurdi Co-Founder and Director, Science and Engineering
David Vorp Co-Founder & Advisor
William Wagner Co-Founder & Advisor
Steve Linhares Vice President of Quality, Clinical & Regulatory

Neograft Technologies Board Members (4)

NameRepresentingRoleSinceContact
Info
John PetersenSelfBoard Member000 0000
Paul SouthworthSelfBoard Member000 0000
Richard Petersen Jr.SelfChairman000 0000
Thomas Dugan MDSelfBoard Member000 0000
John Petersen Board Member Self
Paul Southworth Board Member Self
Richard Petersen Jr. Chairman Self
Thomas Dugan MD Board Member Self
Request full access to PitchBook